Active Monitoring May Be a Safe Treatment Option for Many Women with DCIS Breast Cancer, New Study Suggests

Posted December 14, 2024

In a new study, women with low-risk DCIS breast cancer who underwent active monitoring had similar recurrence rates as women who underwent surgery to remove their cancer.

Health News is provided as a service to LS Pharmacy site users by HealthDay. LS Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!

Active Monitoring May Be a Safe Treatment Option for Many Women with DCIS Breast Cancer, New Study Suggests

Health News is provided as a service to LS Pharmacy site users by HealthDay. LS Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2024 HealthDay All Rights Reserved.

Tags

Site Navigation

Contact Us

Patient Resources

Get Healthy!

Active Monitoring May Be a Safe Treatment Option for Many Women with DCIS Breast Cancer, New Study Suggests

Health News is provided as a service to LS Pharmacy site users by HealthDay. LS Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags

Site Navigation

Contact Us